Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

New phase I study explores BMS-986224 in healthy subjects and heart failure patients

Oct. 9, 2017

Novartis studies LLG-783 in patients with peripheral artery disease and intermittent claudication

Oct. 3, 2017

TLR3 identified as novel target for preventing cardiac ischemia reperfusion injury

Sep. 29, 2017

Board recommends continuation of phase III study of CardiAMP stem cell therapy for heart failure

Sep. 28, 2017

Viera Bioscience presents Act Tregs for cardiovascular disorders

Sep. 20, 2017

Acceleron Pharma, Celgene amend sotatercept agreement

Sep. 20, 2017

Bristol-Myers Squibb describes discovery of phase I anti-PD-L1 candidate BMS-986189

Sep. 19, 2017

New feline model of heart failure with preserved ejection fraction described

Sep. 19, 2017

Pluristem Therapeutics' PLX-PAD given FDA fast track status for critical limb ischemia

Sep. 19, 2017

Cenderitide safe in phase I study in patients with left ventricular assist device support

Sep. 18, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...